Braxia Scientific Corp.
BRAXF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Revenue | $1,884 | $1,487 | $1,008 | $0 |
| % Growth | 26.7% | 47.5% | 475,547.2% | – |
| Cost of Goods Sold | $1,712 | $4,769 | $3,899 | $9 |
| Gross Profit | $172 | -$3,282 | -$2,891 | -$9 |
| % Margin | 9.1% | -220.7% | -286.7% | -4,219.8% |
| R&D Expenses | $98 | $193 | $1,979 | $50 |
| G&A Expenses | $5,471 | $6,463 | $6,179 | $68 |
| SG&A Expenses | $5,623 | $6,716 | $8,026 | $114 |
| Sales & Mktg Exp. | $152 | $253 | $1,848 | $8 |
| Other Operating Expenses | $1,930 | $468 | $682 | $0 |
| Operating Expenses | $7,652 | $7,377 | $10,687 | $164 |
| Operating Income | -$7,480 | -$7,159 | -$10,542 | -$172 |
| % Margin | -397% | -481.4% | -1,045.4% | -81,353.8% |
| Other Income/Exp. Net | -$5,807 | -$5,050 | -$77,910 | -$3,128 |
| Pre-Tax Income | -$13,288 | -$12,176 | -$88,452 | -$173 |
| Tax Expense | -$146 | -$45 | $376 | $0 |
| Net Income | -$13,142 | -$12,134 | -$88,828 | -$173 |
| % Margin | -697.5% | -815.9% | -8,809.1% | -81,473.1% |
| EPS | -0.058 | -0.069 | -0.56 | -0.004 |
| % Growth | 16.9% | 87.6% | -12,627.3% | – |
| EPS Diluted | -0.058 | -0.069 | -0.56 | -0.004 |
| Weighted Avg Shares Out | 228,421 | 175,244 | 157,640 | 39,438 |
| Weighted Avg Shares Out Dil | 228,421 | 175,244 | 157,640 | 39,438 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $18 | $5 | $3 | $0 |
| Depreciation & Amortization | $566 | $11 | $20 | $2 |
| EBITDA | -$12,704 | -$7,136 | -$88,805 | -$3,298 |
| % Margin | -674.2% | -479.9% | -8,806.8% | -1,555,754.2% |